Publikationen in Zusammenarbeit mit Forschern von University Hospital of Geneva (15)

2023

  1. Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

    Genome Medicine, Vol. 15, Núm. 1

  2. Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits

    Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331

2022

  1. Data-driven staging of genetic frontotemporal dementia using multi-modal MRI

    Human Brain Mapping, Vol. 43, Núm. 6, pp. 1821-1835

  2. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

    Molecular Psychiatry, Vol. 27, Núm. 4, pp. 1990-1999

2021

  1. Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia

    Alzheimer's and Dementia, Vol. 17, Núm. 3, pp. 500-514

  2. MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 92, Núm. 6, pp. 608-616

  3. Replication study of plasma proteins relating to Alzheimer's pathology

    Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1452-1464

2020

  1. Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

    Journal of Alzheimer's Disease, Vol. 77, Núm. 3, pp. 1353-1368

  2. Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

    Translational Psychiatry, Vol. 10, Núm. 1

  3. Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort

    Journal of Alzheimer's Disease, Vol. 74, Núm. 1, pp. 213-225

2019

  1. A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

    Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 5, pp. 933-938

  2. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

    Alzheimer's and Dementia, Vol. 15, Núm. 5, pp. 644-654

  3. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

    Alzheimer's and Dementia, Vol. 15, Núm. 11, pp. 1478-1488

  4. Inflammatory biomarkers in Alzheimer's disease plasma

    Alzheimer's and Dementia, Vol. 15, Núm. 6, pp. 776-787

  5. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

    Alzheimer's and Dementia, Vol. 15, Núm. 6, pp. 817-827